THE KILMINSTER PRACTICE LIMITED

Financial Health Score: B-

Explanation: The Kilminster Practice Limited receives a grade of B- due to its strong recovery from a near-fatal "illness" in 2015 and its currently robust liquidity. However, the recent contraction in both total assets and net assets in 2024 indicates a mild, underlying condition—likely a slowing of business activity or a strategic drawing down of reserves—which prevents a higher grade. The patient is stable and out of the emergency room, but showing signs of fatigue.

Key Vital Signs

1. Net Asset Health (Equity): £29,794 * Interpretation: The company’s net worth is positive, which is the financial equivalent of a steady heartbeat. However, this is down from £36,426 in 2023, representing an 18% drop in overall net worth. The patient has lost some healthy tissue recently.

2. Liquidity (Current Ratio): 3.4:1 * Interpretation: Calculated as Current Assets (£45,519) divided by Current Liabilities (£13,373). This is an exceptionally healthy ratio. For every £1 of short-term debt, the company has £3.40 in short-term assets. The company has no risk of cardiac arrest (insolvency) from immediate creditors.

3. Leverage (Debt-to-Equity): 0.52 * Interpretation: Total liabilities (£15,725) compared to net assets (£29,794) shows a low leverage ratio. The business does not suffer from "high blood pressure" caused by excessive debt.

4. Asset Shrinkage: -28.5% * Interpretation: Total assets dropped significantly from £63,716 in 2023 to £45,519 in 2024. This is a notable symptom that requires investigation, as it suggests a contraction in the business's operational scale or the realization (spending) of assets.

Diagnosis

Symptoms Analysis: Looking at the patient's medical history, The Kilminster Practice Limited suffered a severe financial illness in 2015, ending the year with negative net assets (£-20,928)—a state of financial anemia where liabilities heavily outweighed assets. Through careful management, the company staged a remarkable recovery, steadily building its net worth year over year until 2023.

However, the 2024 "check-up" reveals a new symptom: overall shrinkage. Both total assets and net assets have declined. Interestingly, the reduction in assets (£18,197 drop) is much larger than the reduction in net assets (£6,632 drop). This tells us that the company used a significant portion of its assets to pay down both current and long-term liabilities. Current liabilities were reduced by £8,201, and long-term liabilities by £3,364.

Overall Financial Condition: The patient is fundamentally healthy but is currently "shedding weight." The business is contracting in size. Because the filed accounts are "Micro-entity" accounts, we cannot see the profit and loss statement (the detailed blood work), but the shrinking balance sheet suggests either a reduction in revenue generation or the deliberate winding down of retained cash reserves. There are no signs of distress or impending collapse, but the business is smaller than it was a year ago.

Prognosis

The future financial outlook is stable but stagnant. The company has an excellent immune system against short-term shocks (high liquidity) and carries very manageable debt. The primary risk moving forward is not insolvency, but obsolescence or irreversible atrophy. If the 2024 asset shrinkage represents a trend of declining revenue in their financial intermediation niche, the company may slowly fade into dormancy rather than experiencing a sudden failure.

Recommendations

1. Investigate the Cause of Weight Loss: The directors should diagnose exactly why total assets fell by nearly 30% in 2024. Was this a deliberate strategy to draw down cash and pay off creditors, or is the business struggling to generate new revenue? Identifying the root cause is essential to prescribing the right growth strategy.
2. Maintain the Liquidity Buffer: The current ratio of 3.4:1 is very healthy, but ensure that the current assets are not entirely tied up in debtors (money owed by clients). Cash in the bank is the best preventative medicine for unexpected expenses.
3. Strategic Reinvestment: Given the low debt levels, the company is in a prime position to reinvest in the business. To reverse the shrinking balance sheet, consider targeted investments that will "build muscle" and drive future revenue, ensuring the long-term vitality of the practice.